WO2009106641A3 - Compositions and methods for augmentation and regeneration of living tissue in a subject - Google Patents

Compositions and methods for augmentation and regeneration of living tissue in a subject Download PDF

Info

Publication number
WO2009106641A3
WO2009106641A3 PCT/EP2009/052431 EP2009052431W WO2009106641A3 WO 2009106641 A3 WO2009106641 A3 WO 2009106641A3 EP 2009052431 W EP2009052431 W EP 2009052431W WO 2009106641 A3 WO2009106641 A3 WO 2009106641A3
Authority
WO
WIPO (PCT)
Prior art keywords
augmentation
regeneration
subject
living tissue
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/052431
Other languages
French (fr)
Other versions
WO2009106641A2 (en
Inventor
Hanne Everland
Peter Samuelsen
Jakob Vange
Christian Clausen
Monica Ramos Gallego
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Coloplast AS
Original Assignee
Coloplast AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coloplast AS filed Critical Coloplast AS
Priority to CN2009801100428A priority Critical patent/CN102123745A/en
Priority to JP2010548133A priority patent/JP2011512810A/en
Priority to EP09715535A priority patent/EP2291205A2/en
Priority to US12/735,976 priority patent/US20100322908A1/en
Priority to CA2714502A priority patent/CA2714502A1/en
Priority to AU2009218436A priority patent/AU2009218436A1/en
Publication of WO2009106641A2 publication Critical patent/WO2009106641A2/en
Publication of WO2009106641A3 publication Critical patent/WO2009106641A3/en
Anticipated expiration legal-status Critical
Priority to US13/739,020 priority patent/US8877246B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polymers & Plastics (AREA)

Abstract

The present invention provides for a composition, for augmentation and regeneration of living tissue in a subject, comprising a population of porous microparticles of a biodegradable polymer, one or more mammalian cell populations, and optionally, a biocompatible adhesive.
PCT/EP2009/052431 2008-02-29 2009-03-02 Compositions and methods for augmentation and regeneration of living tissue in a subject Ceased WO2009106641A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CN2009801100428A CN102123745A (en) 2008-02-29 2009-03-02 Compositions and methods for augmentation and regeneration of living tissue in a subject
JP2010548133A JP2011512810A (en) 2008-02-29 2009-03-02 Compositions and methods for augmentation and regeneration of biological tissue in a subject
EP09715535A EP2291205A2 (en) 2008-02-29 2009-03-02 Compositions and methods for augmentation and regeneration of living tissue in a subject
US12/735,976 US20100322908A1 (en) 2008-02-29 2009-03-02 Compositions and methods for augmentation and regeneration of living tissue in a subject
CA2714502A CA2714502A1 (en) 2008-02-29 2009-03-02 Compositions and methods for augmentation and regeneration of living tissue in a subject
AU2009218436A AU2009218436A1 (en) 2008-02-29 2009-03-02 Compositions and methods for augmentation and regeneration of living tissue in a subject
US13/739,020 US8877246B2 (en) 2008-02-29 2013-01-11 Compositions and methods for augmentation and regeneration of living tissue in a subject

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200800307 2008-02-29
DKPA200800307 2008-02-29

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/735,976 A-371-Of-International US20100322908A1 (en) 2008-02-29 2009-03-02 Compositions and methods for augmentation and regeneration of living tissue in a subject
US13/739,020 Division US8877246B2 (en) 2008-02-29 2013-01-11 Compositions and methods for augmentation and regeneration of living tissue in a subject

Publications (2)

Publication Number Publication Date
WO2009106641A2 WO2009106641A2 (en) 2009-09-03
WO2009106641A3 true WO2009106641A3 (en) 2010-08-05

Family

ID=40651617

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/052431 Ceased WO2009106641A2 (en) 2008-02-29 2009-03-02 Compositions and methods for augmentation and regeneration of living tissue in a subject

Country Status (7)

Country Link
US (2) US20100322908A1 (en)
EP (2) EP2698173A1 (en)
JP (1) JP2011512810A (en)
CN (1) CN102123745A (en)
AU (1) AU2009218436A1 (en)
CA (1) CA2714502A1 (en)
WO (1) WO2009106641A2 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120071407A1 (en) * 2010-06-18 2012-03-22 Douglas Hamilton Method of treating wounds
WO2012096271A1 (en) * 2011-01-12 2012-07-19 国立大学法人京都大学 Biological adhesive material
US12144843B2 (en) * 2011-06-15 2024-11-19 The Regents Of The University Of California Methods and compositions for modulating myofibroblast activities
CA2870188A1 (en) 2012-04-12 2013-10-17 Howard University Polylactide and calcium phosphate compositions and methods of making the same
TWI653988B (en) 2012-11-09 2019-03-21 Howard University Block copolymer for tooth enamel protection
EP2983728B1 (en) * 2013-04-10 2018-06-06 Agency For Science, Technology And Research Polycaprolactone microcarriers for stem cell culture and fabrication thereof
KR101531091B1 (en) * 2013-07-19 2015-06-24 유재원 Injectable agent for tissue repair treatment comprising the substance polymerizing hydrophobic biocompatible polymer and hydrophilic biocompatible polymer
WO2015019212A1 (en) * 2013-08-09 2015-02-12 Kimberly-Clark Worldwide, Inc. Polymeric material for three-dimensional printing
JP5918736B2 (en) * 2013-09-26 2016-05-18 学校法人福岡大学 Method for producing polylactic acid fine particles
JP2015112262A (en) * 2013-12-11 2015-06-22 学校法人藤田学園 Tissue repair and/or regeneration promoting material
WO2015190430A1 (en) * 2014-06-10 2015-12-17 富士フイルム株式会社 Cell structure and method for producing cell structure
WO2015194494A1 (en) 2014-06-16 2015-12-23 富士フイルム株式会社 Cell structure for use in treatment of brain injury, method for producing same, and therapeutic agent for brain injury
KR20160033897A (en) * 2014-09-19 2016-03-29 주식회사 덱스레보 Composition for tissue repair treatment and methods of manufacturing the same
KR101689357B1 (en) * 2015-03-05 2016-12-26 주식회사 덱스레보 Composition for tissue repair treatment
US10596194B2 (en) * 2015-04-03 2020-03-24 Biochange Ltd. Powder compositions for generating cross-linked protein foams and methods of using thereof
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
KR102464882B1 (en) * 2015-10-12 2022-11-17 주식회사 파마리서치 Method for manufacturing of hollow porous microsphere
KR102404093B1 (en) * 2015-10-14 2022-06-02 주식회사 파마리서치 Injectable composition for regenerating or enhancing volume of skin tissues comprising hollow porous microspheres
JP2016128581A (en) * 2016-02-18 2016-07-14 学校法人福岡大学 Polylactic acid microparticles
CN107349467A (en) * 2016-05-09 2017-11-17 香港大学深圳医院 Degradable magnesia-polymer-based composite bone repairing material
KR101689798B1 (en) * 2016-10-14 2016-12-27 주식회사 덱스레보 Composition for tissue repair treatment and methods of manufacturing the same
CN106421918A (en) * 2016-11-08 2017-02-22 华南生物医药研究院 Chondrocyte composition
CN106421919A (en) * 2016-11-08 2017-02-22 华南生物医药研究院 Composition for cartilage injury repair
CN106421917A (en) * 2016-11-08 2017-02-22 华南生物医药研究院 Method for preparing composition for repairing cartilage injuries
CN106474156A (en) * 2016-11-08 2017-03-08 华南生物医药研究院 Purposes in preparing medicine for the compositionss
US11826488B2 (en) 2017-10-19 2023-11-28 Lifecell Corporation Flowable acellular tissue matrix products and methods of production
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
KR102144479B1 (en) * 2018-05-24 2020-08-13 주식회사 덱스레보 Composition for tissue repair treatment and methods of manufacturing the same
US20210380936A1 (en) * 2018-10-23 2021-12-09 Agency For Science, Technology And Research An Implantable Construct, Methods of Manufacturing, and Uses Thereof
CN109593126B (en) * 2018-11-28 2019-11-22 山西锦波生物医药股份有限公司 Polypeptides, methods for their production and uses
WO2020210520A1 (en) 2019-04-09 2020-10-15 Cdj Technologies, Inc Methodologies to rapidly cure and coat parts produced by additive manufacturing
AU2020283956A1 (en) 2019-05-28 2021-12-16 Cytodigm, Inc. Microparticles and nanoparticles having sulfate groups on the surface
KR20210062378A (en) * 2019-11-21 2021-05-31 (주)바이오트코리아 Functional microscaffold for magnetic drive and the process thereof
US20220401628A1 (en) * 2019-11-22 2022-12-22 Dexlevo Inc. Tissue restoration composition
KR102251192B1 (en) * 2020-08-07 2021-05-13 주식회사 덱스레보 Composition for tissue repair treatment and methods of manufacturing the same
CN116157138A (en) * 2020-09-11 2023-05-23 联邦高等教育系统匹兹堡大学 Process for the preparation and use of terminally sterilized hydrogels or colloidal suspensions derived from extracellular matrix
CN120392974B (en) * 2025-05-12 2025-11-18 上海市东方医院（同济大学附属东方医院） Heart patches containing tendinin C, their preparation methods and uses

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102983A (en) * 1990-04-02 1992-04-07 United States Surgical Corporation Process for preparing foamed, bioabsorbable polymer particles
WO2007101443A1 (en) * 2006-03-09 2007-09-13 Coloplast A/S Degradable hydrophilic block copolymers with improved biocompatibility for soft tissue regeneration

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822741A (en) * 1987-05-04 1989-04-18 Banes Albert J Biocompatible polyorganosiloxane composition for cell culture apparatus
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
US5451406A (en) 1994-07-14 1995-09-19 Advanced Uroscience, Inc. Tissue injectable composition and method of use
CZ138397A3 (en) * 1994-11-08 1997-10-15 Bradley Michael John Stringer Human cellular lines
US20050129673A1 (en) * 1994-12-13 2005-06-16 Stringer Bradley M.J. Chondrocyte cell-lines
US6558664B1 (en) * 1994-12-13 2003-05-06 Cell Factors Plc Chondrocyte cell-lines
US6193577B1 (en) * 1999-09-17 2001-02-27 Mira S. Kaplan Alternative medicine elements package
GB9503492D0 (en) * 1995-02-22 1995-04-12 Ed Geistlich S Hne A G F R Che Chemical product
US5989269A (en) * 1996-08-30 1999-11-23 Vts Holdings L.L.C. Method, instruments and kit for autologous transplantation
US6569172B2 (en) 1996-08-30 2003-05-27 Verigen Transplantation Service International (Vtsi) Method, instruments, and kit for autologous transplantation
US6120514A (en) * 1996-08-30 2000-09-19 Vts Holdings, Llc Method and kit for autologous transplantation
US5759190A (en) * 1996-08-30 1998-06-02 Vts Holdings Limited Method and kit for autologous transplantation
US5989463A (en) * 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US7115417B1 (en) * 1998-05-01 2006-10-03 Chancellor Michael B Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof
US6495152B2 (en) * 2000-08-18 2002-12-17 Tepha, Inc. Sulfur containing polyhydroxyalkanoate compositions and method of production
CZ20032082A3 (en) 2001-01-31 2003-11-12 Interface Biotech A/S Enhanced in vitro cultivation process of mammalian cells for autologous implantation and transplantation methods
CN1514877A (en) 2001-04-12 2004-07-21 ά���������ֲ����ɷݹ�˾ Method for autologous transplantation
KR100973453B1 (en) * 2001-12-07 2010-08-02 제론 코포레이션 Chondrocyte Precursors Derived from Human Embryonic Stem Cells
CZ200624A3 (en) 2003-06-12 2006-05-17 Interface Biotech A/S Method for cell implantation
CN101039683A (en) * 2004-08-13 2007-09-19 血管技术国际有限公司 Compositions and methods using hyaluronic acid and hyaluronidase inhibitors
AU2005272578A1 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors
CN101291586A (en) * 2005-09-02 2008-10-22 英特菲思生物技术公司 Method for Cell Implantation
CN101678049A (en) * 2007-06-15 2010-03-24 伊西康公司 Tissue fragment compositions for the treatment of incontinence

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102983A (en) * 1990-04-02 1992-04-07 United States Surgical Corporation Process for preparing foamed, bioabsorbable polymer particles
WO2007101443A1 (en) * 2006-03-09 2007-09-13 Coloplast A/S Degradable hydrophilic block copolymers with improved biocompatibility for soft tissue regeneration

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KANG AND AL.: "THE USE OF POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERE AS INJECTABLE CELL CARRIERS FOR CARTILAGE REGENERATION IN RABBIT KNEES", J. BIOMATER. SCI. POLYMER EDN, vol. 17, no. 8, 1 January 2005 (2005-01-01), pages 925 - 939, XP008122510 *
NEWMAN K D ET AL: "Poly(d,l lactic-co-glycolic acid) microspheres as biodegradable microcarriers for pluripotent stem cells", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB LNKD- DOI:10.1016/J.BIOMATERIALS.2004.01.027, vol. 25, no. 26, 1 November 2004 (2004-11-01), pages 5763 - 5771, XP004508622, ISSN: 0142-9612 *
SCHNIEDERS J ET AL: "Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB LNKD- DOI:10.1016/J.BIOMATERIALS.2006.03.032, vol. 27, no. 23, 1 August 2006 (2006-08-01), pages 4239 - 4249, XP025097543, ISSN: 0142-9612, [retrieved on 20060801] *
XU AND ALL: "SOFT, POROUS POLY(D,L-LACTIDE-CO-GLYCOLIDE) MICROCARRIERS DESIGNED FOR EX-VIVO STUDIES AND FOR TRANSPLANTATION OF ADHERENT CELL TYPES INCLUDING PROGENITORS", ANNALS NEW YORK ACADEMY OF SCIENCES, vol. 944, 26 January 2001 (2001-01-26), pages 144 - 159, XP002583407 *

Also Published As

Publication number Publication date
CA2714502A1 (en) 2009-09-03
AU2009218436A1 (en) 2009-09-03
EP2291205A2 (en) 2011-03-09
WO2009106641A2 (en) 2009-09-03
CN102123745A (en) 2011-07-13
JP2011512810A (en) 2011-04-28
US20100322908A1 (en) 2010-12-23
US8877246B2 (en) 2014-11-04
US20130251758A1 (en) 2013-09-26
EP2698173A1 (en) 2014-02-19

Similar Documents

Publication Publication Date Title
WO2009106641A3 (en) Compositions and methods for augmentation and regeneration of living tissue in a subject
WO2009007852A3 (en) Multipotent/pluripotent cells and methods
IN2012DN00570A (en)
EP2910568A3 (en) Methods and compositions for generation of BAX- and BAK-deficient cell lines
WO2010120757A3 (en) Regeneration of tissue without cell transplantation
WO2009092082A3 (en) Composite implants and methods of making and using the same
EP2034955A4 (en) Collagen scaffolds, medical implants with same and methods of use
EP2578081A3 (en) Compositions, methods, and devices for treating liver disease
WO2007030743A3 (en) Cochlear implants containing biological cells and uses thereof
WO2005077013A3 (en) Surface directed cellular attachment
WO2008147817A3 (en) Coated hyaluronic acid particles
EP2740498A3 (en) Compositions and methods for tissue filling and regeneration
EP1737506A4 (en) Implant scaffold combined with autologous or allogenic tissue
WO2010054013A3 (en) Cell-scaffold constructs
EP4406557A3 (en) Materials and methods for improving gastrointestinal function
WO2009158033A3 (en) Antagonists of activin-actriia and uses for increasing red blood cell levels
EP2727998A3 (en) Methods for purifying pancreatic endoderm cells derived from human embryonic stem cells
WO2008024640A3 (en) Biodegradable elastomeric scaffolds containing microintegrated cells
EP2358301A4 (en) REGENERATIVE TISSUE GRAFT AND METHODS OF MAKING THE SAME
WO2011109433A9 (en) Tissue for prosthetic implants and grafts, and methods associated therewith
WO2009142770A3 (en) Compositions and methods for generating musculoskeletal tissue
WO2009086305A3 (en) Osteoinductive putties and methods of making and using such putties
WO2014152102A3 (en) Bioactive porous bone graft implants
WO2011137292A3 (en) Injectable, load-bearing cell/microbead/calcium phosphate bone paste for bone tissue engineering
WO2010102123A3 (en) A matrix that prolongs growth factor release

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980110042.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09715535

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2009218436

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2009715535

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2010548133

Country of ref document: JP

Ref document number: 12735976

Country of ref document: US

Ref document number: 2714502

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2009218436

Country of ref document: AU

Date of ref document: 20090302

Kind code of ref document: A